World's Best Scientists 2026 revealed!
Rafick P. Sekaly

Rafick P. Sekaly

D-Index & Metrics

Immunology

D-Index
73
Citations
21915
World Ranking
2119
National Ranking
1031

Rafick P. Sekaly publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rafick P. Sekaly sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 216 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rafick P. Sekaly D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rafick P. Sekaly sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Virus

His scientific interests lie mostly in Immunology, Virology, T cell, Antigen and Interleukin 21. His Viral replication, Immune system and T-cell receptor study are his primary interests in Immunology. His Virology study incorporates themes from Human leukocyte antigen and Major histocompatibility complex.

His Antigen research incorporates elements of Molecular biology and Viral load. Interleukin 21 is a subfield of Cytotoxic T cell that Rafick Pierre Sekaly studies. He combines subjects such as Cell biology, IL-2 receptor, CCL5 and Antigen-presenting cell with his study of CD8.

His most cited work include:

  • Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction (1242 citations)
  • Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction (1242 citations)
  • Skewed maturation of memory HIV-specific CD8 T lymphocytes (959 citations)

What are the main themes of his work throughout his whole career to date?

Rafick Pierre Sekaly mainly focuses on Immunology, Virology, T cell, Immune system and Cytotoxic T cell. His research in Virology intersects with topics in Interleukin 2 and CTL*. He works mostly in the field of Interleukin 2, limiting it down to concerns involving Interferon gamma and, occasionally, Interleukin.

His T cell study integrates concerns from other disciplines, such as Receptor, Peripheral blood mononuclear cell and Antigen. While the research belongs to areas of Cytotoxic T cell, Rafick Pierre Sekaly spends his time largely on the problem of Cancer research, intersecting his research to questions surrounding Stem cell. His Interleukin 21 study frequently links to other fields, such as IL-2 receptor.

He most often published in these fields:

  • Immunology (78.87%)
  • Virology (44.37%)
  • T cell (40.14%)

What were the highlights of his more recent work (between 2013-2021)?

  • Immunology (78.87%)
  • Virology (44.37%)
  • Immune system (29.58%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, Virology, Immune system, Cancer research and Inflammation. Rafick Pierre Sekaly combines topics linked to Cytotoxic T cell with his work on Immunology. The study incorporates disciplines such as Proliferative capacity and Antigen in addition to Cytotoxic T cell.

His work on Viremia as part of general Virology research is frequently linked to Nonhuman primate, Cocaine use, Proviral dna and Heroin, bridging the gap between disciplines. His Inflammation study which covers Pathogenesis that intersects with Macrophage and Interferon. His study explores the link between Interleukin 21 and topics such as IL-2 receptor that cross with problems in CD28, Antigen-presenting cell and Natural killer T cell.

Between 2013 and 2021, his most popular works were:

  • Normalizing the environment recapitulates adult human immune traits in laboratory mice (541 citations)
  • CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART (191 citations)
  • Sequential Infection with Common Pathogens Promotes Human-like Immune Gene Expression and Altered Vaccine Response (121 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Virus

His primary areas of investigation include Immunology, Immune system, Immunity, T cell and Virology. Rafick Pierre Sekaly usually deals with Immunology and limits it to topics linked to Lymph and Cellular compartment. His Immune system research is multidisciplinary, relying on both Specific-pathogen-free, Specific Pathogen Free Organism, Blood cell and Laboratory mouse.

He has included themes like Virus latency, Cytotoxic T cell and Cytokine in his T cell study. His Cytokine research includes elements of Interleukin 12, Cell biology, IL-2 receptor and CD8. His Interleukin 21 study is focused on Antigen in general.

Best Publications

  • Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction

    Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said

  • Skewed maturation of memory HIV-specific CD8 T lymphocytes

    P Champagne;G S Ogg;A S King;C Knabenhans

  • Normalizing the environment recapitulates adult human immune traits in laboratory mice

    Lalit K. Beura;Sara E. Hamilton;Kevin Bi;Jason M. Schenkel

  • Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

    G Pantaleo;J F Demarest;H Soudeyns;C Graziosi

  • Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells.

    Antoine Alam;Luchino Y. Cohen;Salah Aouad;Rafick-Pierre Sékaly

  • HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity

    Souheil Antoine Younes;Bader Yassine-Diab;Alam R. Dumont;Alam R. Dumont;Mohamed Rachid Boulassel

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

    Cecilia Graziosi;Giuseppe Pantaleo;Kira R. Gantt;Jean-Pierre Fortin

  • Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.

    Marcus Altfeld;Marylyn M. Addo;Eric S. Rosenberg;Frederick M. Hecht

  • CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

    Rémi Fromentin;Wendy Bakeman;Mariam B. Lawani;Gabriela Khoury;Gabriela Khoury

  • Peripheral Blood CCR4 + CCR6 + and CXCR3 + CCR6 + CD4 + T Cells Are Highly Permissive to HIV-1 Infection

    Annie Gosselin;Patricia Monteiro;Nicolas Chomont;Felipe Diaz-Griffero

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

    Giuseppe Pantaleo;James F. Demarest;Timothy Schacker;Mauro Vaccarezza

  • Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

    Marina Caskey;François Lefebvre;Abdelali Filali-Mouhim;Mark J. Cameron

  • Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.

    Philip J.R. Goulder;Philip J.R. Goulder;Marcus A. Altfeld;Eric S. Rosenberg;Thi Nguyen

  • HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation

    Marie Lise Dion;Jean François Poulin;Rebeka Bordi;Myriam Sylvestre

  • Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow

    Jaeyop Lee;Gaëlle Breton;Thiago Yukio Kikuchi Oliveira;Yu Jerry Zhou

  • Direct Evidence for Thymic Function in Adult Humans

    Jean François Poulin;Mohan N. Viswanathan;Jeffrey M. Harris;Krishna V. Komanduri

  • A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

    Francesco Andrea Procopio;Rémi Fromentin;Deanna A. Kulpa;Jessica H. Brehm

  • Standardization of cytokine flow cytometry assays

    Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

Frequent Co-Authors

Jean-Pierre Routy
Jean-Pierre Routy McGill University Health Centre
Nicolas Chomont
Nicolas Chomont University of Montreal
Elias K. Haddad
Elias K. Haddad Drexel University
Mirko Paiardini
Mirko Paiardini Emory University
Jacob D. Estes
Jacob D. Estes Oregon Health & Science University
Giuseppe Pantaleo
Giuseppe Pantaleo University of Lausanne
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Joseph M. McCune
Joseph M. McCune University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open doors to diverse healthcare careers. Many students pursue advanced nursing roles, with programs tailored for specific areas like psychiatric mental health. Finding the cheapest pmhnp certificate programs is a practical way to start, offering affordability without compromising quality.

Nurses aiming to elevate their expertise often consider a Doctorate in Nursing Practice (DNP). Understanding the doctorate in nursing salary landscape can help prospective students weigh the financial benefits of this advanced degree.

Career growth can also involve transitioning between specialties. For example, those with a Family Nurse Practitioner (FNP) background may seek an fnp to acute care certification to expand their skill set and clinical impact in acute care environments.

To accelerate these ambitions, many turn to streamlined programs designed for working professionals. The availability of accelerated fnp programs enables quicker entry into advanced practice roles, bridging the gap between foundational nursing experience and specialized immunology-related careers.

Best Scientists Citing Rafick P. Sekaly

Trending Scientists

Recently Published Articles